Skip to main content

Table 1 Demographics of the study population

From: Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation

Variables Healthy subjects (n = 15) DCM (n = 12) ICM (n = 10) P value
Age (years) 50.5 ± 6.5 49.3 ± 16.0 54.9 ± 7.3 0.475
Male (n, %) 13 (86.7) 11 (91.7) 9 (90.0) 1.000
Height (cm) 167.3 ± 4.4 167.4 ± 6.4 168.3 ± 4.6 0.889
Weight (kg) 68.5 ± 9.4 65.2 ± 18.8 66.5 ± 5.6 0.869
BMI (kg/m2) 24.4 ± 3.0 25.0 ± 3.7 23.1 ± 1.2 0.321
BSA (m2) 1.81 ± 0.14 1.77 ± 0.25 1.79 ± 0.07 0.967
Heart rate (bpm) 64 ± 7 83 ± 18* 75 ± 17 0.023
Haematocrit (%) 42.5 ± 3.8 41.9 ± 2.9 39.7 ± 6.6 0.675
Hypertension (n, %) 0 (0) 3 (25.0) 4 (40.0)
Diabetes mellitus (n, %) 0 (0) 4 (33.3) 4 (40.0)
Hyperlipidaemia (n, %) 0 (0) 1 (8.3) 2 (20.0)
Smoker (n, %) 6 (40.0) 4 (33.3) 7 (70.0) 0.263
Family history of coronary artery disease (n, %) 0 (0.0) 0 (0.0) 0 (0.0)
Duration (years) 6.5 ± 3.7 2.2 ± 1.5
Time between CMR and transplantation (days) 15 ± 11 27 ± 35
NYHA functional class III/IV (n, %) 2 (16.7)/10 (83.3) 1 (10.0)/9 (90.0)
NT-proBNP (pg/mL) 4680.9 ± 6064.7 3294.0 ± 3482.7
BUN (mmol/L) 8.6 ± 5.1 7.5 ± 3.0
Creatinine (μmol/L) 107.8 ± 51.5 125.8 ± 81.6
  1. Values are expressed as the mean ± SD or n (%)
  2. *p <  0.05 vs. controls
  3. DCM Dilated cardiomyopathy, ICM Ischaemic cardiomyopathy, BMI Body mass index, BSA Body surface area, CMR Cardiac magnetic resonance, NYHA New York Heart Association, NT-proBNP N-terminal pro-brain natriuretic peptide, BUN Blood urea nitrogen